A Study to Evaluate the Safety and Efficacy of Itacitinib in Moderate to Severe Ulcerative Colitis

Summary

The purpose of this study is to evaluate the efficacy and safety of itacitinib in participants with moderate to severe ulcerative colitis (UC).

Timeline

Start

2018-09-20

Primary completion

2019-11-13

Completion

2019-11-13

Outcome

Outcome not reported

Stopped (Enrollment): “Study withdrawn due to lack of recruitment. No patients enrolled. No safety concerns.”

Drugs

Indications